RARE Hospitality International, Inc. (RARE)

Sector:
CONSUMER DISCRETIONARY
Industry:
RESTAURANTS
SIC:
RETAIL-EATING PLACES
CEO:
Emil D. Kakkis
Employees:
1,310
60 LEVERONI COURT, NOVATO, CA 94949
415-483-8800

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Ultragenyx Pharmaceutical Inc. focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the. treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia.

Data derived from most recent annual or quarterly report
Market Cap 1.3 Billion Shares Outstanding34.071 Million Avg 30-day Volume 611.325 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-3.5
Price to Revenue6.2282 Debt to Equity0.0 EBITDA-582.786 Million
Price to Book Value80.5587 Operating Margin-144.5099 Enterprise Value2.027 Billion
Current Ratio2.359 EPS Growth0.077 Quick Ratio2.053
1 Yr BETA 1.1642 52-week High/Low 0.0 / Profit Margin-154.8694
Operating Cash Flow Growth-39.7069 Free Cash Flow to Firm (FCFF) TTM -459.656 Million Free Cash Flow to Equity (FCFE) TTM-484.441 Million
Altman Z-Score-3.3405

Are you looking for these stocks instead?

View SEC Filings from RARE instead.

View recent insider trading info

Funds Holding RARE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RARE

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

Events (8k)

Proposed Sales (Form 144)

Proxy

Prospectus

All

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SAN MARTIN RONALD W

  • Director
0 2007-10-01 0

JORDAN LEWIS H

  • Director
0 2007-10-01 0

HICKEY PHILIP J JR CEO AND CHAIRMAN OF THE BOARD

  • Officer
26,976 2007-10-01 0

BYRD CAROLYN H

  • Director
0 2007-10-01 0

CHAPMAN DON L

  • Director
0 2007-10-01 0

BOEVE ROGER L

  • Director
0 2007-10-01 0

HOLBROOK DICK R

  • Director
0 2007-10-01 0

BENN W DOUGLAS CHIEF FINANCIAL OFFICER

  • Officer
9,786 2007-10-01 0

GATHERS THOMAS W EXECUTIVE VP-HUMAN RESOURCES

  • Officer
5,271 2007-10-01 0

LEE EUGENE I JR PRESIDENT AND COO-RARE

  • Officer
  • Director
22,215 2007-10-01 0

GEORGE DAVID C VICE PRESIDENT

  • Officer
  • PRESIDENT-LONGHORN STEAKHOUSE
5,337 2007-10-01 0

MARTIN JOHN VICE PRESIDENT

  • Officer
  • PRESIDENT-CAPITAL GRILLE
5,091 2007-10-01 0

WAITES BENJAMIN A CHIEF ACCOUNTING OFFICER

  • Officer
3,846 2007-10-01 0

DIXON JAMES D

  • Director
5,625 2006-12-28 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

WhaleWisdom Logo

Elevate your investments